No. 04

Ana Banito awarded for her research on soft tissue sarcomas

Ana Banito, scientist at the DKFZ and the KITZ, received the award of the Berlin-Brandenburg Academy of Sciences (BBAW) – donated by the Monika Kutzner Foundation – for her work on sarcomas
Ana Banito, scientist at the DKFZ and the KITZ, received the award of the Berlin-Brandenburg Academy of Sciences (BBAW) – donated by the Monika Kutzner Foundation – for her work on sarcomas

Ana Banito, scientist at the German Cancer Research Center (DKFZ) and the Hopp Children's Cancer Center Heidelberg" (KiTZ) received the Award of the Berlin-Brandenburg Academy of Sciences and Humanities for her work on sarcomas, a group of malignant tumors which is quite common in children. The prize, donated by the Monika Kutzner Foundation and endowed with 10,000 euros, is awarded annually for special achievements that advance cancer research. The "Hopp Children's Cancer Center Heidelberg" (KiTZ) is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD) and Heidelberg University.

“I feel very grateful and honored to receive this prestigious award and I am happy to see research on sarcoma receiving more visibility,“ says Ana Banito. The 38-year-old Portuguese leads a junior group at the KiTZ. Previously, she has worked at the Memorial Sloan Kettering Cancer Center in New York at the Institute of Cancer Researcher Scott Lowe for several years.

Ana Banito is an expert in the biology of soft tissue sarcomas, tumors that can emerge from a variety of tissues of the body. Soft tissue sarcomas account for about seven percent of all childhood and adolescent cancers. They are thus the third most common solid tumors in children and adolescents. Many subspecies of soft tissue sarcomas in children and young adults are based on a common genetic mechanism. Meanwhile, a number of characteristic mutations are known in the genetics of the sarcoma cells that drive the malignant growth of cancer cells.

Banito and her research group genetically mimic these changes in order to better understand the biological processes underlying the development of the disease and to find therapeutic molecules that can stop the tumor growth. The team also explores the role of incorrect regulation of chemical modifications of the genome, the so-called epigenetic modifications, in childhood sarcomas.

The prize of the Berlin-Brandenburg Academy of Sciences and Humanities – donated by the Monika Kutzner Foundation – is endowed with € 10,000. It is awarded for outstanding achievements in the field of cancer research.

An image for this press release is available for download at:
https://www.kitz-heidelberg.de/fileadmin/media/kitz/news/2020/BBAW-Preis-Ana-Banito.jpeg 

Caption:
Ana Banito, scientist at the DKFZ and the KITZ, received the award of the Berlin-Brandenburg Academy of Sciences (BBAW) – donated by the Monika Kutzner Foundation – for her work on sarcomas.

Note on use of images related to press releases
Use is free of charge. The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) permits one-time use in the context of reporting about the topic covered in the press release. Images have to be cited as follows: “Source: Judith Affolter“.
Distribution of images to third parties is not permitted unless prior consent has been obtained from DKFZ's Press Office (phone: ++49-(0)6221 42 2854, E-mail: presse@dkfz.de). Any commercial use is prohibited.

About DKFZ

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)

The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.

Form

Form data is loaded ...